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Available online 9 November 2016Background: Ventricular noncompaction is characterized by excessive trabeculations and is associatedwith heart
failure. The lesion is hypothesized to result from failed compaction and thus retention of embryonic
trabeculations. Here, we assess for the ﬁrst time the identity of trabeculations in noncompaction to test whether
noncompacted hearts show retention of embryonic trabeculations.
Methods: Using immunohistochemistry, we analyzed cardiac sections of the heart of a control embryo, 3 cases of
fetal noncompaction (a set of twins and an unrelated fetus) and 3 fetal hearts without noncompaction.
Results: In the embryo, the ventricular trabeculations strongly expressed ANF/NPPA whereas the compact wall
did not. In the noncompaction hearts, trabeculations constituted an excessively thick layer. In noncompaction
and control fetal hearts alike, however, only a miniscule subset of sub-endocardial myocardium of the
trabeculations most proximal to the central ventricular lumen exhibited strong expression of ANF/NPPA,
representing Purkinje myocardium. The trabeculations of both fetal control and noncompaction hearts were
ANF-negative and orders of magnitude wider than those of the embryo. Both the compact and noncompaction
trabeculated myocardium were rich in coronary vasculature. Like embryonic trabeculations, the ANF+ Purkinje
myocardium had little if any vasculature.
Conclusion: The excessive trabeculations in noncompaction do not have the embryonic identity and
noncompaction is probably not the result of failed compaction. We propose the lesion results from the compact
wall growing into the ventricular lumen in a trabecular fashion.





Cardiac conduction system1. Introduction
Left ventricular noncompaction or hypertrabeculation is a cardiomy-
opathy characterized by excessive trabeculations and is associated with
a high risk of heart failure and sudden cardiac death [1,2]. The lesion is
thought to result from failed compaction of the embryonic
trabeculations, whereby an excessive amount of trabeculations linger
in the ventricular lumen [1].
Heart development sees the formation of a loopedheart tube. Cham-
bers grow at the outer curvatures of the looped heart tube and the
expanding ventricles start to acquire trabeculations from around week
4 [3]. Within days, trabeculations become the bulk of the ventriculary, Embryology & Physiology,
, Meibergdreef 15, 1105AZ
eliability and freedom from bias
land Ltd. This is an open access articlmyocardium, giving the ventricles a ‘spongy’ appearance.Mouse studies
show the trabeculations grow by proliferation at their base at the con-
nection with the compact wall, which at this point is only a few cell
layers thick [4]. The embryonic trabeculations are less than 50 μm
wide, only a few cells across, without coronary vasculature, and rich in
ANF/NPPA and CX40/GJA5 [3,5]. By gestational week 6 in human,
the trabeculations have effectively ceased to proliferate, whereas
the compact walls continue to grow, by which the ventricles expand
exteriorly and a ventricular lumen develops [3,6]. The embryonically
formed trabeculations will therefore constitute a progressively smaller
part of the ventricular myocardial mass during the fetal period. Mean-
while they maintain the ANF and CX40 positive phenotype and will
eventually give rise to the Purkinje network of the conduction system
[7–9].
Here we compare normal and noncompacted fetal human hearts
and show the Purkinje myocardium is not excessive in noncompaction.
This ﬁnding is surprising if one expects noncompaction to develop from
excessive embryonic trabeculations, but is not surprising given mouse
models of noncompaction [10,11] showing the compact wall growing
into the ventricular lumen in a trabecular fashion.e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2.1. Study subjects
Parafﬁn blocks containing biventricular transmural slices of fetal
hearts were retrieved from the pathology archives of the Academic
Medical Center Amsterdam. Selected cases were fetuses of which preg-
nancywas terminated at 20–21weeks gestation formultiple congenital
defects, which were diagnosed during prenatal echography. Permission
for autopsy was retrieved from their relatives, and parafﬁn blocks were
used anonymously for the purpose of this study, following institutional
guidelines. Selected cases included 3 hearts (NC1, 2 and 3) with a diag-
nosis of ventricular noncompaction based on the ratio of left ventricular
trabeculated versus compacted myocardium greater than 2.3:1, as was
measured on a haematoxylin and eosin (HE) stained section of the tis-
sue blocks. NC1 and 2 were from identical twins with multiple cardiac
abnormalities and NC3 was an unrelated case derived from external
consultation for diagnostic purposes. As referencematerials we selected
heart slices of two structurally normal hearts (N1, N2) and a case of hy-
pertrophy due to severe valvar abnormalities and without excessive
trabeculations (N3). As reference for the normal embryonic condition
we adapted images from a previous study [12].2.2. Immunohistochemistry
Parafﬁn sections adjacent to the HE stained section were cut serially
and used for immunohistochemistry. The following primary antibodies
were used: cTnI (ab-19615), cTnI (HyTest 4T21/2), cTnI (sc-15368),
ANF (sc-20158), HCN4 (sc-28750) and CX40 (sc-20466). Secondary an-
tibodies were Alexa from Invitrogen raised in donkey with conjugated
ﬂuorophores emitting light at wave lengths 488 nm, 568 nm, and
680 nm. Nuclei were detected using Dapi (D9542, Sigma) or SYTOX®
Blue (Molecular Probes). For detection of endotheliumweused a prima-
ry antibody against CD31 (clone JC70A, Dakopatts, Denmark), which
was visualized with DAB+ (Dako) in an immunoperoxidase stain and
faintly counterstained with haematoxylin.3. Results
3.1. Trabeculations in the embryo
Ventricular trabeculations in a normal embryo of 6 weeks expressed
NPPA (ANF) (Fig. 1A). The atria were also rich in NPPA. In contrast, NPPA
was essentially absent from the compact wall of both ventricles and the
compact ventricular septum (Fig. 1A).3.2. Trabeculations in noncompaction are much greater than in the embryo
The width of the embryonic trabeculations was approximately
50 μm or less. In contrast, in all cases of fetal noncompaction (NC1-3),
the trabeculations were typically 1–2 mmwide, which is up to 2 orders
of magnitude wider than in the embryo (compare Fig. 1A to B–J). The
trabeculations were generally of the same magnitude in healthy and
noncompacted hearts alike.Fig. 1. The embryonic trabeculations develop similarly in normal, hypertrophic and noncomp
expression of NPPA (in situ hybridization, false colors) in the atria and ventricular trabecula
ventricles is conﬁned to a tiny subset of sub-endocardial myocardium of presumed Purkinj
expression in the hypertrophic fetal heart resembles that of B–C except there is an additional
NC3) rich ANF expression was only in a tiny subset of sub-endocardial myocardium of presum
heart (A). IVS, ventricular septum; LV, left ventricle; RV, right ventricle.3.3. Restriction of expression of ANF, CX40 and HCN4 to Purkinje myocardi-
um in all fetal hearts
In the structurally normal fetal heart of N1, ANFwas abundantly de-
tected in the left and right atria (Fig. 1B). In contrast, the compact wall,
septum and trabeculations of both left and right ventricles did not show
ANF expression. ANF was only detected in small populations of sub-
endocardial myocardium taken to be Purkinje myocardium (Fig. 1B).
Similarly, strong expression of ANF in the transverse sections of N2
was shown in the sub-endocardial myocardium proximal to the central
lumen of the left and right ventricles (Fig. 1C). Diffuse and less strong
expression of ANF was detected in both the trabeculated and compact
wall. In the ventricles of N3, ANF expression was strongest in the sub-
endocardial myocardium proximal to the central lumen of the left and
right ventricles. Diffuse and less strong expression of ANF was detected
in the transitional region between the trabeculated and compact wall
(Fig. 1D). Similarly, in all cases of fetal noncompaction (NC1-3), strong
expression of ANF was only found in the sub-endothelial myocardium
in the inner most part of the ventricles (Fig. 1E–J). Some diffuse and
less strong expression could be detected (e.g. Fig. 1J), very much like
in the hypertrophic ventricles without excessive trabeculations of N3
(Fig. 1D). HCN4 and CX40 were poorly detected in our autopsymaterial
but showed co-expression with ANF (Fig. 2).
3.4. Coronary vasculature was abundant, except in the ANF+ Purkinje
ﬁbers
In all three reference hearts, vascular endothelium (CD31-positive)
was abundant in both the compact and trabeculated myocardium.
Only the ventricular sub-endocardial myocardium rich in ANF showed
little vasculature (Fig. 3A–B). In the noncompacted ventricles there
was extensive vascularization of both the compact wall and the exces-
sive trabeculations (Fig. 3C–D). Only sub-endothelial myocardium of
the central most trabeculations, Purkinje myocardium had little if any
vasculature (Fig. 3C–D).
4. Discussion
In the cases of noncompaction cardiomyopathy studied here, the
fetal trabeculations in general were different from embryonic
trabeculations by being wider, having coronary vasculature, and show-
ing little if any expression of ANF. The trabeculations in noncompaction
instead much more resembled the trabeculations of the normal heart.
Noncompaction, therefore cannot be considered a retention of the em-
bryonic design. We observed strong expression of Purkinje markers
only in a tiny subset of the subendocardial myocardium of the
trabeculationsmost proximal to the ventricular lumen. Such limited ex-
tent of the Purkinje myocardium in the fetal cases of noncompaction is
difﬁcult to reconcile with common notions of the etiology of
noncompaction. If noncompaction results from the failure to compact
embryonic trabeculations, or from an excessive formation of embryonic
trabeculations, there should be a greater substrate for the Purkinjemyo-
cardium to develop from andwewould then expect to ﬁnd an excessive
Purkinje network. But we did not observe an excessive Purkinje net-
work. Instead, the limited extent of the Purkinje myocardium in both
normal and noncompacted hearts suggests that the embryonicacted hearts as revealed by ANF expression (green). A (tiny image, top left). Embryonic
tions (*). A is oriented and scaled to B. B–C. Rich expression of ANF in the normal fetal
e myocardium (arrow heads and insert) of the ventricular conduction system. D. ANF
diffuse expression of ANF. In the three cases of noncompaction (E–F, NC1; G–H, NC2; I–J,
ed Purkinje myocardium, as in the non-noncompacted hearts but unlike the embryonic
Fig. 2.Detection of ventricular Purkinjemyocardium (ANF, HCN4, CX40) andmyocardiumwith three different antibodies for troponin I in fetal noncompaction (specimenNC1; compared
to insert of Fig. 1F). Myocardium with high expression of ANF generally co-expressed HCN4 and CX40. Oppositely, sarcomeric proteins were generally less expressed in ANF rich
myocardium.
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models show that noncompaction can be caused by abnormal formation
of the compact wall, whereby excessive trabeculations are formed with
themolecular phenotype of the compact wall [10,11]. Here, we provide
the ﬁrst observations in human tissue based on molecular markers,
which are consistent with the ﬁndings in these mouse models.
It is widely believed the compact wall grows by compaction of the
embryonic trabeculations [2]. However, it is unlikely that compaction
contributes substantially to growth of the compact wall of themamma-
lian heart. By gestational week 6 in human, when some 34 weeks and
many orders of magnitude of growth remains, the trabeculations have
already ceased to proliferate [3]. In contrast, the compact wall exhibits
tremendous proliferation rates by which it expands and thickens [3].
The compact wall therefore outgrows the trabeculations prior to thesupposed onset of compaction in week 12 [13]. Even if one allows for
extensive compaction of the embryonic trabeculations, the resulting ad-
dition to the compact wall will only add little mass to the much larger
compact wall, which exhibits persistent growth by intrinsic prolifera-
tion. Similar and more detailed ﬁndings on growth of the ventricular
wall have beenmade inmice [4,13]. Thus, compaction is unlikely to con-
tribute much, if anything, to ventricular compact wall formation.
The Purkinje myocardium of both noncompacted and normal fetal
hearts and the trabeculations of the embryonic heart share properties:
they express ANF, are smaller than the fetal trabeculations, and lack vas-
cularization. This suggests the formation and maturation of the embry-
onic trabeculationsmay be normal in the three cases of non-compaction
we present. That the Purkinje myocardium was only a small fraction of
all ventricular myocardium in both the healthy and noncompacted
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bryonic trabeculations. The poor vascularization of the Purkinje net-
work suggests this myocardium resists differentiation to a phenotype
that resembles that of the compactwall. Nevertheless, Purkinjemyocar-
dium of the fully formed postnatal heartmay bemore vascularized [14].
Extensive Purkinje myocardium could potentially explain the ob-
served association of noncompaction with malignant ventricular ar-
rhythmias [1], but we see no evidence for extensive Purkinje
myocardium in our cases of fetal noncompaction. If noncompaction isFig. 3.Extensive coronary vascularization (CD31detection, brown)of ventricular trabeculations
in the left bundle branch (LBB) of the ventricular conduction system. B. In the hypertrophic lef
noncompacted ventricles, there was extensive vascularization. Only the sub-endothelial myoc
region as the insert of Figs. 1F and 2, but from a different histological section.the outcome of abnormal compact wall maturation [10,11], there is no
need to expect extensive Purkinje myocardium in the ﬁrst place. Ven-
tricular arrhythmias may arise from a multitude of factors unrelated to
Purkinje myocardium, such as ﬁbrosis and heterogeneity in repolariza-
tion [15].
Fig. 4 summarizes current views on ventricular wall formation,
which all start from the highly trabeculated embryonic ventricle. In nor-
mal development, the highly trabeculated state is succeeded by
sustained proliferation of the compact wall, while the original. A. Left septal surface of thenormal fetal heart (N1) showing absence of vasculature (avasc)
t ventricle (LV) of N3 vasculature could be absent in myocardium rich in ANF. C–D. In the
ardium of the central-most trabeculation could be avascular; image C4 is from the same
Fig. 4. Normal development of the ventricular wall and three hypothesized etiologies of
noncompaction. Normal development encompasses an early formation of trabeculations
from a thin compact wall with which it shares molecular phenotype (Embryo, green).
Later, the compact wall (grey) outgrows the trabeculations by greater proliferation
(Fetus) and no longer expresses ANF and CX40. The embryonically formed
trabeculations will give rise to the Purkinje network (Perinatal). Our data on ANF and
coronary vascularization support noncompaction caused by malformation of the
compact wall whereby trabeculations are formed with a compact wall phenotype. Our
data do not support noncompaction as the outcome of excessive formation of
embryonic-like trabeculations.
330 B. Jensen et al. / International Journal of Cardiology 227 (2017) 325–330trabeculations growmuch less andwill give rise to the small population
of Purkinje myocardium. The relatively tiny mass of the Purkinje myo-
cardium in noncompaction reported here, lead us to conclude that the
embryonic trabeculationswere formed normally, and, therefore, the ex-
cessive trabeculations result from abnormal (trabecular-like) growth of
the compact wall myocardium. If noncompaction results from excessive
formation of embryonic trabeculations, we suggest the Purkinje myo-
cardium should be extensive in the noncompacted ventricles. Ventricu-
lar development in ectothermic vertebrates is illustrative, because it
appears to exhibit actual retention of the embryonic design, a setting
that is certainly different from noncompaction [6]. In conclusion,
noncompaction likely results from abnormal growth of the compact
wall.Grant support
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